Graduate School of Medical Sciences

Researchers at Weill Cornell Medicine have discovered in a preclinical model that cytokines, proteins that control immune response, circulating in maternal blood during pregnancy may mitigate an offspring's risk for psychiatric conditions.

Microbes in the mammalian gut can significantly change their hosts’ amino acid and glucose metabolism, acting almost like an extra liver, according to a new preclinical study by Weill Cornell Medicine investigators.

Dr. Carl Nathan, chair of the department of microbiology and immunology and the R.A. Rees Pritchett Professor of Microbiology at Weill Cornell Medicine, answers questions about interferon-γ's history and future.

Weill Cornell Medicine’s Celebration of Diversity, part of the institution’s sixth annual Diversity Week, was held on April 15. The awardees were honored for their commitment to diversity and inclusivity in academic medicine through exemplary contributions in mentorship, research, clinical care, community service and advocacy.

Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.

Launched in 2019, the IMSD Program aims to boost admissions and retention rates of doctoral students primarily from self-identified historically underrepresented groups in science. 

Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain—a process that drives cognitive decline in Alzheimer's disease and frontotemporal dementia. 

A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients.

The 2024 Health Hackathon brought together 185 students with diverse backgrounds from Cornell and 26 other universities—in just 36 hours, they addressed critical safety challenges facing patients today.

A collaboration between Dr. Jedd Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, and Dr. Yelena Janjigian, chief of the gastrointestinal oncology service at Memorial Sloan Kettering Cancer Center, is looking to transform the care of gastroesophageal cancer (GEC) patients with untreatable disease – earning the pair a grant from Stand Up To Cancer® (SU2C) as a part of the SU2C-Torrey Coast Foundation Gastroesophageal Cancer Dream Team Collective.

A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.

For younger Black patients living in rural parts of the Southeastern United States, peer coaching is more effective than traditional clinical care in controlling high blood pressure, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. 

The program aims to cultivate scientists and physician-scientists who hail from groups traditionally underrepresented in science and medicine.

Important signaling molecules called phospholipids are active throughout cells in small compartments called condensates, rather than functioning primarily in cell membranes as previously thought, according to a study from researchers at Weill Cornell Medicine.

The Parker Institute for Cancer Immunotherapy (PICI) announced it has added Weill Cornell Medicine to its network of preeminent academic and medical research institutions at the forefront of the fight against cancer. 

The eleven students from the Weill Cornell Graduate School of Medical Sciences and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences participated in the eighth annual Three-Minute Thesis (3MT®) competition, which challenged the young scientists to trim the scientific jargon and share their thesis projects creatively.

The institution is constructing a modern new student residence that, when it opens in 2025, will expand the scope of the institution’s Upper East Side campus and nearly double the existing student residential living space.

For the sixth consecutive year, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity (HEED) Award by INSIGHT Into Diversity magazine, which recognizes the institution’s exceptional commitment to diversity and inclusion.

Researchers at Weill Cornell Medicine have illuminated one of the important ways that cells respond to stress. The findings could also be relevant to Alzheimer’s, ALS and other diseases in which this mechanism may be abnormally active.

Weill Cornell Medicine has received a three-year, nearly $6 million grant to lead one of three national contraceptive research centers.